Home › Funds › PeakShares LLC › REGN

PeakShares LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

PeakShares LLC reported holding 2,813 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 1.37% of its reported portfolio and ranking #21 among its reported holdings. PeakShares LLC has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.81K sh
Reported value held$2.13M
Portfolio Weight1.37%
First reportedQ4 2025
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PeakShares LLC's REGN position evolved

PeakShares LLC first disclosed a stake in REGN in Q4 2025 at 1,428 shares (US$1.1M). The position peaked in Q2 2026 at 1,564 shares, worth US$975.2M. Across 4 filings, PeakShares LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,813 shares valued at US$2.1M — an increase of 1,249 shares quarter over quarter.. Notable position changes include a 80% increase in Q3 2026 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.43K $1.10M New
Q1 2026 1.45K $1.12M Add
Q2 2026 1.56K $975.22M Add
Q3 2026 2.81K $2.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 30 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has PeakShares LLC held REGN?

PeakShares LLC has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PeakShares LLC's current position in REGN?

As of Q3 2026, PeakShares LLC holds 2.81K shares of REGN (REGENERON PHARMACEUTICALS), valued at $2.13M, representing 1.37% of its reported portfolio and ranking #21.

Has PeakShares LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), PeakShares LLC increased its position in REGN. The position peaked in Q2 2026 at 1.56K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Nuveen, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.